NCT00761592View on ClinicalTrials.gov

Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Blepharospasm
Interventions
BIOLOGICAL

Botulinum Toxin Type A 900kDa

6 to 16 injections, with maximum of 21, at a dose of ≥20U/eye (≥40U total dose)

BIOLOGICAL

Botulinum Toxin Type A 150kDa

6 to 16 injections, with a maximum of 21, at a dose of ≥20U/eye (≥40U total dose)

Trial Locations (3)

Unknown

Bonn

Wiesbaden

Zwickau

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY